Company intelligence / Profile preview

Vgenomics

Ownership: Private
Employees: ~11
Development stage: Preclinical

Overview

Vgenomics offers diagnostic services including Non-Invasive Prenatal Testing (NIPT), targeted Next-Generation Sequencing (tNGS) for Tuberculosis, and Whole Exome Sequencing (WES) for rare diseases. They recently partnered with Meril Genomics to expand access to these diagnostics across India[5].

Therapeutic areas: Women's HealthRare DiseasesInfectious Diseases
Modalities: Genomic sequencingblood testsAI-driven analytics
Industry: Molecular Diagnostics

Partnerships

Meril Genomics[5]

Beyond the preview

Go deeper on Vgenomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vgenomics.

Explore the full profile